Induced Abortion and Out-of-State Travel Among Insured Women Before and After the

Ilina C Odouard, Jenny S Guadamuz, Apurba Chakraborty, G Caleb Alexander, Dima M Qato

Abstract read

In one paragraph

Article in O&G open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Abortion Surveillance - United States, 2022.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ilina C OdouardDepartment of Health Policy and Management, the Center for Drug Safety and Effectiveness, and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and the Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland; and the Division of Health Policy and Management, University of California, Berkeley School of Public Health, Berkeley, and the Program on Medicines and Public Health, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, and the Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California.

Jenny S GuadamuzDepartment of Health Policy and Management, the Center for Drug Safety and Effectiveness, and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and the Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland; and the Division of Health Policy and Management, University of California, Berkeley School of Public Health, Berkeley, and the Program on Medicines and Public Health, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, and the Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California.

Apurba ChakrabortyDepartment of Health Policy and Management, the Center for Drug Safety and Effectiveness, and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and the Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland; and the Division of Health Policy and Management, University of California, Berkeley School of Public Health, Berkeley, and the Program on Medicines and Public Health, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, and the Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California.

G Caleb AlexanderDepartment of Health Policy and Management, the Center for Drug Safety and Effectiveness, and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and the Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland; and the Division of Health Policy and Management, University of California, Berkeley School of Public Health, Berkeley, and the Program on Medicines and Public Health, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, and the Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California.

Dima M QatoDepartment of Health Policy and Management, the Center for Drug Safety and Effectiveness, and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and the Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland; and the Division of Health Policy and Management, University of California, Berkeley School of Public Health, Berkeley, and the Program on Medicines and Public Health, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, and the Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo quantify changes in abortion rates and out-of-state travel for abortion among insured women before and after the

methodsThis was a cross-sectional analysis of IQVIA's anonymized, patient-level preadjudicated medical claims on induced medication or procedural abortions among 43.1 million insured women of reproductive age (15-49 years) in the United States. We used information from the Guttmacher Institute to stratify states based on post-

resultsBetween January 2021 and December 2022, a total of 212,875 women of reproductive age (mean±SD age 28.1±6.5 years) had at least one induced abortion. In a comparison of the pre-

conclusionThere was a modest increase in abortion rates among insured women nationally after

Identifiers

PMID41000583

DOI10.1097/og9.0000000000000016

PMCPMC12456511

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.